120 related articles for article (PubMed ID: 38621607)
1. Safety and Efficacy of Stereotactic Body Radiation Therapy for Ultra-central Thoracic Tumors: A Single Center Retrospective Review.
Li GJ; Tan H; Nusrat H; Chang J; Chen H; Poon I; Shahi J; Tsao M; Ung Y; Cheung P; Louie AV
Int J Radiat Oncol Biol Phys; 2024 Apr; ():. PubMed ID: 38621607
[TBL] [Abstract][Full Text] [Related]
2. Tumor Control and Toxicity after SBRT for Ultracentral, Central, and Paramediastinal Lung Tumors.
Nguyen KNB; Hause DJ; Novak J; Monjazeb AM; Daly ME
Pract Radiat Oncol; 2019 Mar; 9(2):e196-e202. PubMed ID: 30496842
[TBL] [Abstract][Full Text] [Related]
3. Five- Versus Ten-Fraction Regimens of Stereotactic Body Radiation Therapy for Primary and Metastatic NSCLC.
Steber CR; Hughes RT; Soike MH; Jacobson T; Helis CA; Farris JC; Farris MK
Clin Lung Cancer; 2021 Jan; 22(1):e122-e131. PubMed ID: 33046359
[TBL] [Abstract][Full Text] [Related]
4. Safety and Efficacy of Stereotactic Body Radiotherapy in Ultracentral Lung Tumors Using a Risk-optimized Fractionation Scheme.
Regnery S; Eichkorn T; Weykamp F; Held T; Weusthof K; Dinges LA; El-Shafie RA; Winter H; Thomas M; Debus J; Adeberg S; Hörner-Rieber J
Clin Lung Cancer; 2021 Jul; 22(4):332-340.e3. PubMed ID: 33281061
[TBL] [Abstract][Full Text] [Related]
5. Stereotactic Body Radiation Therapy for Mediastinal and Hilar Lymph Node Metastases.
Shahi J; Poon I; Ung YC; Tsao M; Bjarnason GA; Malik NH; Zhang L; Louie AV; Cheung P
Int J Radiat Oncol Biol Phys; 2021 Mar; 109(3):764-774. PubMed ID: 33115687
[TBL] [Abstract][Full Text] [Related]
6. Local control and toxicity in a large cohort of central lung tumors treated with stereotactic body radiation therapy.
Modh A; Rimner A; Williams E; Foster A; Shah M; Shi W; Zhang Z; Gelblum DY; Rosenzweig KE; Yorke ED; Jackson A; Wu AJ
Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1168-76. PubMed ID: 25303891
[TBL] [Abstract][Full Text] [Related]
7. Ultra-central lung tumors: safety and efficacy of protracted stereotactic body radiotherapy.
Lodeweges JE; van Rossum PSN; Bartels MMTJ; van Lindert ASR; Pomp J; Peters M; Verhoeff JJC
Acta Oncol; 2021 Aug; 60(8):1061-1068. PubMed ID: 34191670
[TBL] [Abstract][Full Text] [Related]
8. The safety and effectiveness of stereotactic body radiotherapy for central versus ultracentral lung tumors.
Chang JH; Poon I; Erler D; Zhang L; Cheung P
Radiother Oncol; 2018 Nov; 129(2):277-283. PubMed ID: 30049454
[TBL] [Abstract][Full Text] [Related]
9. Assessment of Monte Carlo algorithm for compliance with RTOG 0915 dosimetric criteria in peripheral lung cancer patients treated with stereotactic body radiotherapy.
Pokhrel D; Sood S; Badkul R; Jiang H; McClinton C; Lominska C; Kumar P; Wang F
J Appl Clin Med Phys; 2016 May; 17(3):277-293. PubMed ID: 27167284
[TBL] [Abstract][Full Text] [Related]
10. Ultracentral Tumors Treated With Stereotactic Body Radiotherapy: Single-Institution Experience.
Raman S; Yau V; Pineda S; Le LW; Lau A; Bezjak A; Cho BCJ; Sun A; Hope AJ; Giuliani M
Clin Lung Cancer; 2018 Sep; 19(5):e803-e810. PubMed ID: 30007498
[TBL] [Abstract][Full Text] [Related]
11. Uncovering the armpit of SBRT: An institutional experience with stereotactic radiation of axillary metastases.
Mutsaers A; Li GJ; Fernandes JS; Ali S; Barnes EA; Chen H; Czarnota GJ; Karam I; Moore-Palhares D; Poon I; Soliman H; Vesprini D; Cheung P; Louie AV
Clin Transl Radiat Oncol; 2024 Mar; 45():100730. PubMed ID: 38317679
[TBL] [Abstract][Full Text] [Related]
12. Ten fraction hypofractionated stereotactic body radiotherapy for the management of ultracentral lung tumors: a retrospective analysis of dosimetry, outcomes, and toxicity.
Rock C; Sood S; Cao Y; Shelton S; Chen RC; Wang F
Radiat Oncol; 2023 Aug; 18(1):128. PubMed ID: 37533092
[TBL] [Abstract][Full Text] [Related]
13. Stereotactic ablative radiotherapy of 60 Gy in eight fractions is safe for ultracentral non-small cell lung cancer.
Yang D; Cui J; Zhao J; You J; Yu R; Yu H; Jiang L; Li D; Xu B; Shi A
Thorac Cancer; 2020 Mar; 11(3):754-761. PubMed ID: 32012484
[TBL] [Abstract][Full Text] [Related]
14. Moderately Hypofractionated Radiotherapy Alone for Stage I-IIB Non-small Cell Lung Cancer.
Hughes RT; Helis CA; Soike MH; Levine BJ; Farris M; Blackstock AW
Cureus; 2019 Jun; 11(6):e4969. PubMed ID: 31453041
[TBL] [Abstract][Full Text] [Related]
15. Lobar Gross Endobronchial Disease Predicts for Overall Survival and Grade 5 Pulmonary Toxicity in Medically Inoperable Early Stage Non-Small Cell Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy.
Aghdam N; Lischalk JW; Marin MP; Hall C; O'Connor T; Campbell L; Suy S; Collins SP; Margolis M; Krochmal R; Anderson E; Collins BT
Front Oncol; 2021; 11():728519. PubMed ID: 34912703
[TBL] [Abstract][Full Text] [Related]
16. Risk-adapted stereotactic body radiation therapy for central and ultra-central early-stage inoperable non-small cell lung cancer.
Meng MB; Wang HH; Zaorsky NG; Sun BS; Zhu L; Song YC; Li FT; Dong Y; Wang JS; Chen HM; Yu XY; Yuan ZY
Cancer Sci; 2019 Nov; 110(11):3553-3564. PubMed ID: 31464032
[TBL] [Abstract][Full Text] [Related]
17. Toxicity and Efficacy of Multitarget Thoracic Stereotactic Body Radiation Therapy.
Nguyen EK; Poon I; Ung YC; Tsao M; Korol R; Elzibak AH; Erler D; Zhang L; Louie AV; Cheung P
Int J Radiat Oncol Biol Phys; 2023 Mar; 115(4):897-905. PubMed ID: 36368432
[TBL] [Abstract][Full Text] [Related]
18. Analysis of pneumonitis and esophageal injury after stereotactic body radiation therapy for ultra-central lung tumors.
Wang C; Rimner A; Gelblum DY; Dick-Godfrey R; McKnight D; Torres D; Flynn J; Zhang Z; Sidiqi B; Jackson A; Yorke E; Wu AJ
Lung Cancer; 2020 Sep; 147():45-48. PubMed ID: 32663723
[TBL] [Abstract][Full Text] [Related]
19. Safety and Efficacy of Stereotactic Ablative Radiotherapy for Ultra-Central Lung Cancer.
Wang B; Dong Y; Yu X; Li F; Wang J; Chen H; Niu Z; Song Y; Yuan Z; Tao Z
Front Oncol; 2022; 12():868844. PubMed ID: 35600391
[TBL] [Abstract][Full Text] [Related]
20. Stereotactic body radiotherapy for Ultra-Central lung Tumors: A systematic review and Meta-Analysis and International Stereotactic Radiosurgery Society practice guidelines.
Yan M; Louie AV; Kotecha R; Ashfaq Ahmed M; Zhang Z; Guckenberger M; Kim MS; Lo SS; Scorsetti M; Tree AC; Sahgal A; Slotman BJ
Lung Cancer; 2023 Aug; 182():107281. PubMed ID: 37393758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]